Aldehyde dehydrogenase 2 partly mediates hypotensive effect of nitrite on L-NAME-induced hypertension in normoxic rat

Clinical and Experimental Hypertension

Volumn 36, Issue 6, 2014, Pages 410-418

  Sonoda, Kunihiro ^a   Ohtake, Kazuo ^b   Kubo, Yoshinori ^b   Uchida, Hiroyuki ^b   Uchida, Masaki ^b   Natsume, Hideshi ^b   Kobayashi, Miya ^a   Kobayashi, Jun ^b  

^a KINJO GAKUIN UNIVERSITY   (Japan)

^b JOSAI UNIVERSITY   (Japan)

Author keywords

Aldehyde dehydrogenase 2; Hypertension; Nitric oxide; Nitrite; Xanthine oxidase

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 2; CHLORAL HYDRATE; CYANAMIDE; GLYCEROL 1,2 DINITRATE; GLYCERYL TRINITRATE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRITE; SODIUM NITRITE; 1,1-DIETHYL-2-HYDROXY-2-NITROSOHYDRAZINE; ALDEHYDE DEHYDROGENASE; ALDH2 PROTEIN, RAT; ANTIHYPERTENSIVE AGENT; HYDRAZINE DERIVATIVE; MITOCHONDRIAL PROTEIN; NITRIC ACID DERIVATIVE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CATALYSIS; CONTROLLED STUDY; DOSE RESPONSE; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PLASMA CLEARANCE; RAT; VASODILATATION; ANIMAL; BLOOD; BLOOD PRESSURE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME;

ALDEHYDE DEHYDROGENASE; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDRAZINES; HYPERTENSION; MALE; MITOCHONDRIAL PROTEINS; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE; NITROGLYCERIN; RATS; RATS, SPRAGUE-DAWLEY; SODIUM NITRITE; TIME FACTORS;

EID: 84907022318     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2013.846355     Document Type: Article

References (51)

1. Lundberg JO, Weitzberg E, Lundberg JM, Alving K. Intragastric nitric oxide production in humans: measurements in expelled air. Gut 1994;35:1543-6.
2. Shiva S, Huang Z, Grubina R, et al. Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res 2007;100:654-61.
3. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008;7:156-67.
4. van Faassen EE, Bahrami S, Feelisch M, et al. Nitrite as regulator of hypoxic signaling in mammalian physiology. Med Res Rev 2009; 29:683-741.
5. Zweier JL, Li H, Samouilov A, Liu X. Mechanisms of nitrite reduction to nitric oxide in the heart and vessel wall. Nitric oxide 2010;22:83-90.
6. Dezfulian C, Raat N, Gladwin MT. Role of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics. Cardiovasc Res 2007;75:327-38.
7. Benjamin N, O'Driscoll F, Dougall H, et al. Stomach NO synthesis. Nature 1994;368:502.
8. Cosby K, Partovi KS, Crawford JH, et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 2003;9:1498-505.
9. Millar TM, Stevens CR, Benjamin N, et al. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett 1998;427:225-8.
10. Castello PR, David PS, McClure T, et al. Mitochondrial cytochrome oxidase produces nitric oxide under hypoxic conditions: implications for oxygen sensing and hypoxic signaling in eukaryotes. Cell Metab 2006;3:277-87.
11. Zuckerbraun BS, Shiva S, Ifedigbo E, et al. Nitrite potently inhibits hypoxic and inflammatory pulmonary arterial hypertension and smooth muscle proliferation via xanthine oxidoreductasedependent nitric oxide generation. Circulation 2010;121:98-109.
12. Kevil CG, Kolluru GK, Pattillo CB, Giordano T. Inorganic nitrite therapy: historical perspective and future directions. Free Radic Biol Med 2011;51:576-93.
13. Dejam A, Hunter CJ, Pelletier MM, et al. Erythrocytes are the major intravascular storage sites of nitrite in human blood. Blood 2005;106:734-9.
14. Gladwin MT, Shelhamer JH, Schechter AN, et al. Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc Natl Acad Sci USA 2000;97: 11482-7.
15. Chen Z, Zhang J, Stamler JS. Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci USA 2002;99:8306-11.
16. Li H, Cui H, Kundu TK, et al. Nitric oxide production from nitrite occurs primarily in tissues not in blood. Critical role of xanthine oxidase and aldehyde oxidase. J Biol Chem 2008;283:17855-63.
17. Animal ethics in cardiovascular research. Cardiovasc Res 2012;93:1-3.
18. Tsuchiya K, Kanematsu Y, Yoshizumi M, et al. Nitrite is an alternative source of NO in vivo. Am J Physiol Heart Circ Physiol 2005;288:H2163-217.
19. Buelke-Sam J, Holson JF, Bazare JJ, Young JF. Comparative stability of physiological parameters during sustained anesthesia in rats. Lab Anim Sci 1978;28:157-62.
20. Kera Y, Ohbora Y, Komura S. The metabolism of acetaldehyde and not acetaldehyde itself is responsible for in vivo ethanol-induced lipid peroxidation in rats. Biochem Pharmacol 1988;37:3633-8.
21. Hellstrom E, Tottmar O. Effects of aldehyde dehydrogenase inhibitors on enzymes involved in the metabolism of biogenic aldehydes in rat liver and brain. Biochem Pharmacol 1982;31: 3899-905.
22. Janero DR, Bryan NS, Saijo F, et al. Differential nitros(yl)ation of blood and tissue constituents during glyceryl trinitrate biotransformation in vivo. Proc Natl Acad Sci USA 2004;101:16958-63.
23. Huellner MW, Schrepfer S, Weyand M, et al. Inhibition of aldehyde dehydrogenase type 2 attenuates vasodilatory action of nitroglycerin in human veins. FASEB J 2008;22:2561-8.
24. Ohtake K, Ishiyama Y, Uchida H, et al. Dietary nitrite inhibits early glomerular injury in streptozotocin-induced diabetic nephropathy in rats. Nitric Oxide 2007;17:75-81.
25. Patel RP, Hogg N, Kim-shapiro DB. The potential role of the red blood cell in nitrite dependent regulation of blood flow. Cardiovasc Res 2011;89:507-15.
26. Shiva S. Review: mitochondria as metabolizers and targets of nitrite. Nitric Oxide 2010;22:64-74.
27. Ohtake K, Nakanishi K, Uchida H, et al. Second international meeting on the role of nitrite in physiology, pathophysiology, and therapeutics. Natcher conference center, National Institutes of Health; 2007; Bethesda, MD (Abstract).
28. Badejo Jr AM, Hodnette C, Dhaliwal JS, et al. Mitochondrial aldehyde dehydrogenase mediated vasodilator responses of glyceryl trinitrate and sodium nitrite in the pulmonary vascular bed of the rat. Am J Physiol Heart Circ Physiol 2010;299:H819-26.
29. Romanin C, Kukovetz WR. Guanylate cyclase activation by organic nitrates is not mediated via nitrite. J Mol Cell Cardiol 1988;20: 389-96.
30. Beretta M, Gruber K, Kollau A, et al. Bioactivation of nitroglycerin by purified mitochondrial and cytosolic aldehyde dehydrogenases. J Biol Chem 2008;283:17873-80.
31. Kollau A, Beretta M, Russwurm M, et al. Mitochondrial nitrite reduction coupled to soluble guanylate cyclase activation: lack of evidence for a role in the bioactivation of nitroglycerin. Nitric Oxide 2009;20:53-60.
32. Wenzl MV, Beretta M, Griesberger M, et al. Site-directed mutagenesis of aldehyde dehydrogenase-2 suggests three distinct pathways of nitroglycerin biotransformation. Mol Pharmacol 2011; 80:258-66.
33. Pluta RM, Jung CS, Harvey-White J, et al. In vitro and in vivo effects of probucol on hydrolysis of asymmetric dimethyl L-arginine and vasospsm in primates. J Neurosurg 2005; 103:731-8.
34. Dias-Junior CAC, Gladwin MT, Tanus-Santos JE. Low-dose intravenous nitrite improves hemodynamics in a canine model of acute pulmonary thromboembolism. Free Radic Biol Med 2006;41: 1764-70.
35. Pluta RM, Oldfield EH, Bakhtian KD, et al. Safety and feasibibility of long-term intravenous sodium nitrite infusion in healthy volunteers. PLoS One 2011;6:1-13.
36. Nossaman BD, Pankey EA, Badejo Jr AR, et al. Analysis of responses to glyceryl trinitrate and sodium nitrite in the intact chest rat. Nitric Oxide 2012;26:223-8.
37. Pankey EA, Badejo Jr AR, Casey DB, et al. Effect of chronic sodium nitrite therapy on monocrotaline-induced pulmonary hypertension. Nitric Oxide 2012;27:1-8.
38. Arif S, Feelisch M, Horowitz JD, et al. Aldehyde dehydrogenase plays an important role in nitrite-mediated vasorelaxation during hypoxic conditions. Nitric Oxide 2013;31:S37.
39. Koppaka V, Thompson DC, Chen Y, et al. Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharmacol Rev 2012;64:520-39.
40. Dungel P, Haindl S, Behling T, et al. Neither nitrite nor nitric oxide mediate toxic effects of nitroglycerin on mitochondria. J Biochem Mol Toxicol 2011;25:297-302.
41. Hendgen-Cotta UB, Merx MW, Shiva S, et al. Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury. Proc Natl Acad Sci USA 2008;105:10256-61.
42. Ormerod JOM, Ashrafian H, Maher AR, et al. The role of vascular myoglobin in nitrite-mediated blood vessel relaxation. Cardiovasc Res 2011;89:560-5.
43. Totzeck M, Hendgen-Cotta UB, Luedike P, et al. Nitrite regulates hypoxic vasodilation via myoglobin-dependent nitric oxide generation. Circulation 2012;126:325-34.
44. Gladwin MT, Schechter AN, Kim-Shapiro DB, et al. Meeting report: the emerging biology of the nitrite anion. Nat Chem Biol 2005;1:308-14.
45. Huang KT, Keszler A, Patel N, et al. The reaction between nitrite and deoxyhemoglobin. J Biol Chem 2005;280:31126-31.
46. Huang Z, Shiva S, Kim-Shapiro DB, et al. Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J Clin Invest 2005;115:2099-107.
47. Crawford JH, Isbell TS, Huang Z, et al. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood 2006;107:566-74.
48. Bryan NS, Fernandez BO, Bauer SM, et al. Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat Chem Biol 2005;1:290-7.
49. Li H, Samouilov A, Liu X, Zweier JL. Characterization of the effects of oxygen on xanthine oxidase-mediated nitric oxide formation. J Biol Chem 2004;279:16939-46.
50. Feelisch M, Fernandez BO, Bryan NS, et al. Tissue processing of nitrite in hypoxia. An intricate interplay of nitric oxide-generating and scavenging systems. J Biol Chem 2008;283:33927-34.
51. Beretta M, Wolkart G, Schernthaner M, et al. Vascular bioactivation of nitroglycerin is catalyzed by cytosolic aldehyde dehydrogenase-2. Circ Res 2012;110:385-93.